Table 9.
Study sample and plan
| Number of subjects (worldwide, regions) | ||||
|---|---|---|---|---|
| Effect evaluation during coronavirus crisis Health Cube questionnaire (effect-pre) | n 20.05.2020 | Process-evaluation Health Cube (process) | n 10.01.2021 | After crisis Health Cube (post); planned not in all countries |
| North Europe (Germany, Poland, | 615 | Germany Form | 900 | All |
| United Kingdom, Latvia, | A, B, C, D, E | |||
| Norway, Netherlands) | ||||
| South Europe (Italy, Portugal, | 280 | All | ||
| Spain) | ||||
| Africa (South Africa, Ethiopia) | 50 | |||
| South America (Mexico, | 190 | |||
| Argentina, Chile) | ||||
| North America (USA, Canada) | 20 | |||
| South East Asia (Indonesia) | 160 | A, B | ||
| Middle East (Iran, Israel) | 160 | |||
| Australia | 25 | |||
| Sum (subjects) | 1500 | 900 | N = 2400 | |